What is the recommended work‑up and treatment for a patient presenting with elevated protein C, neuritis, and retinal hemorrhages?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Workup and Management of Elevated Protein C, Neuritis, and Retinal Hemorrhages

Immediate Priority: Rule Out Giant Cell Arteritis (GCA)

If the patient is over 50 years old with neuritis (optic neuritis) and retinal hemorrhages, immediately initiate high-dose corticosteroids (prednisone 40-60 mg daily or methylprednisolone 1g IV) before any diagnostic testing to prevent irreversible bilateral blindness from GCA. 1, 2, 3, 4

Critical Clinical Assessment for GCA

  • Ask specifically about new-onset persistent headache (especially temporal), jaw claudication, scalp tenderness, and constitutional symptoms (fever, weight loss, fatigue) 1, 3, 4
  • Palpate temporal arteries for tenderness, thickening, or decreased pulse 3
  • Perform funduscopy to assess for optic disc edema and the pattern of retinal hemorrhages 1
  • Do not delay corticosteroids while awaiting laboratory results or temporal artery biopsy—this is the most dangerous error and the strongest risk factor for permanent blindness 1, 3, 4

Urgent Laboratory Testing (Draw Before Treatment, But Do Not Wait for Results)

  • ESR and CRP immediately (elevated in >95% of GCA cases, but 11% have normal inflammatory markers) 1, 3, 4
  • Complete blood count with platelets (assess for thrombocytosis or anemia) 4
  • If GCA is suspected based on age >50, visual symptoms, and headache, treat immediately regardless of laboratory results 2, 3, 4

Secondary Differential: Systemic Lupus Erythematosus (SLE) with Neuropsychiatric Manifestations

When to Consider SLE-Related Optic Neuritis

  • If patient is younger (<50 years), female, or has known autoimmune disease history 1
  • Optic neuritis with retinal hemorrhages can occur in SLE, particularly with antiphospholipid antibody syndrome 1
  • Funduscopy showing optic disc edema (30-40% of cases) with peripapillary and peripheral retinal hemorrhages suggests inflammatory optic neuritis 1

Diagnostic Workup for SLE-Related Disease

  • Brain and orbital MRI with gadolinium contrast (shows optic nerve enhancement in 60-70% of inflammatory optic neuritis) 1
  • Antiphospholipid antibodies (lupus anticoagulant, anticardiolipin antibodies, anti-β2-glycoprotein I) 1
  • Visual evoked potentials to detect bilateral optic nerve involvement 1
  • Fluorescein angiography if vaso-occlusive retinopathy suspected 1

Treatment for SLE-Related Optic Neuritis

  • Pulse intravenous methylprednisolone combined with intravenous cyclophosphamide 1
  • Consider anticoagulation if antiphospholipid antibodies are positive and patient does not respond to immunosuppressive therapy 1
  • Prognosis is poor: only 30% maintain visual acuity >20/25, and relapses are common requiring chronic immunosuppressive therapy 1

Thrombophilia Workup: Elevated Protein C Context

Understanding the Protein C Finding

The phrase "elevated protein C" is unusual—protein C deficiency (not elevation) causes thrombotic complications including retinal vascular occlusions 5, 6, 7. If the laboratory report truly shows elevated protein C, this may represent:

  • Acute phase reactant elevation (inflammatory state) 6
  • Laboratory error requiring repeat testing 6
  • Acquired elevation from oral contraceptives, pregnancy, or other hormonal states 6

If Protein C Deficiency is Present (Corrected Interpretation)

  • Protein C deficiency causes retinal arteriolar occlusions and can present with retinal hemorrhages 5, 6
  • Prevalence of protein C/S deficiency in retinal vascular occlusion is low overall, but important in young patients (<50 years) 6, 7
  • Screen for factor V Leiden mutation (resistance to activated protein C)—present in 29% of central retinal vein occlusions 7

Comprehensive Thrombophilia Panel

  • Protein C activity and antigen levels 6, 7
  • Protein S (free and total) 6, 7
  • Antithrombin III 6
  • Factor V Leiden mutation (R506Q) by PCR 7
  • Antiphospholipid antibodies (lupus anticoagulant, anticardiolipin, anti-β2-glycoprotein I) 1, 7
  • Homocysteine level 8
  • Testing should be performed when patient is not acutely ill and not on anticoagulation 6

Retinal Vascular Occlusion Workup

Immediate Ophthalmologic Assessment

  • Visual acuity testing and visual field examination 1
  • Slit-lamp biomicroscopy with iris examination for neovascularization 1
  • Intraocular pressure measurement 1
  • Dilated funduscopy to characterize hemorrhage pattern (peripapillary vs. peripheral, presence of Roth spots) 1, 9
  • Fluorescein angiography to assess for vaso-occlusive retinopathy and areas of non-perfusion 1

Stroke/TIA Workup (Retinal Artery Occlusion = "Eye Stroke")

  • Immediate referral to emergency department with stroke center capability—retinal artery occlusion has the same silent cerebral ischemia rate as hemispheric TIA 1, 2
  • Brain MRI with diffusion-weighted imaging to evaluate for acute cerebral infarction 1, 4
  • Carotid ultrasound or CTA/MRA to evaluate for carotid stenosis 1, 4
  • Echocardiography to assess for cardiac embolic sources 1
  • Antiplatelet therapy (aspirin) and statin therapy apply to the vast majority of patients 1

MOG Antibody-Associated Disease (MOGAD)

When to Consider MOGAD

  • Optic neuritis with severe optic disc edema, peripapillary hemorrhages, peripheral retinal hemorrhages, and Roth spots 9
  • Typically presents with painful visual loss 9
  • More common in younger patients 9

Diagnostic Testing

  • Serum MOG (myelin oligodendrocyte glycoprotein) antibodies 1, 9
  • Orbital MRI showing hyperintensity in optic nerve with gadolinium enhancement 9
  • If co-existing transverse myelitis, also test for NMO IgG (aquaporin-4) antibodies 1

Treatment

  • Early intravenous high-dose corticosteroids rapidly improve visual acuity and fundus abnormalities 9
  • Retinal hemorrhages resolve rapidly with treatment 9

Treatment Algorithm Based on Age and Presentation

Age >50 Years with Optic Neuritis and Retinal Hemorrhages

  1. Immediately start prednisone 40-60 mg daily (or methylprednisolone 1g IV if severe) 3, 4
  2. Draw ESR/CRP but do not wait for results 3, 4
  3. Same-day ophthalmology and rheumatology consultation 3, 4
  4. Arrange temporal artery biopsy within 2 weeks (remains diagnostic after steroid initiation) 3, 4
  5. Brain MRI to exclude stroke 4

Age <50 Years with Optic Neuritis and Retinal Hemorrhages

  1. Urgent brain and orbital MRI with gadolinium 1, 9
  2. Serum MOG antibodies and comprehensive autoimmune panel (ANA, anti-dsDNA, antiphospholipid antibodies) 1, 9
  3. Thrombophilia panel if retinal vascular occlusion pattern present 6, 7
  4. Pulse IV methylprednisolone (typically 1g daily for 3-5 days) 1, 9
  5. Consider IV cyclophosphamide if SLE-related 1

Any Age with Retinal Artery Occlusion Pattern

  1. Immediate ED referral to stroke center 1, 2
  2. Brain MRI with DWI sequences 1, 4
  3. Carotid imaging and echocardiography 1, 4
  4. Antiplatelet and statin therapy 1
  5. Monitor for neovascularization requiring panretinal photocoagulation 1

Critical Pitfalls to Avoid

  • Never attribute new-onset headache with visual symptoms to migraine in patients >50 years—always rule out GCA first 3
  • Never delay corticosteroids for GCA while pursuing neuroimaging or awaiting biopsy 3, 4
  • Never assume "elevated protein C" is protective—verify the result and consider protein C deficiency as the actual pathology 5, 6
  • Never dismiss retinal hemorrhages in optic neuritis as benign—they indicate severe inflammation or vascular occlusion requiring urgent treatment 1, 9
  • Never forget that retinal artery occlusion requires the same urgent stroke workup as hemispheric TIA 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acute Blindness Workup in the Elderly

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Giant Cell Arteritis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Giant Cell Arteritis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Recurrent multiple-branch retinal arteriolar occlusions in a patient with protein C deficiency.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 1989

Research

Retinal vascular occlusion and deficiencies in the protein C pathway.

American journal of ophthalmology, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.